M-H Stern Selected Research

Neoplasms (Cancer)

1/2018	Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.
8/2013	MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M-H Stern Research Topics

Disease

2	Leukemia 01/2021 - 01/2020
2	Neoplasms (Cancer) 01/2018 - 08/2013
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2018
1	Ewing Sarcoma (Sarcoma, Ewing) 08/2013

Drug/Important Bio-Agent (IBA)

2	Thomsen-Friedenreich antibodiesIBA 01/2021 - 01/2020
2	tinostamustineIBA 01/2021 - 01/2020
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 08/2013
1	Transcription Factors (Transcription Factor)IBA 08/2013
1	Biomarkers (Surrogate Marker)IBA 08/2013
1	EWS-FLI fusion proteinIBA 08/2013

Therapy/Procedure

1	Therapeutics 01/2018